Courtesy FDA
The February 2, 2012 recall of dietary products by Healthy People Co. is being expanded. The brand names of the recalled products are listed below. This update recalls all listed products regardless of their lot number. The products were sold on or before October 25, 2011 and were distributed nationwide.
The products may contain Sibutramine and Tadalafil, which are FDA-approved drugs. The presence of those drugs in these products makes the products unapproved new drugs. Sibutramine has been withdrawn from the U.S. market because people taking it had an increased risk of heart attack and stroke. For more information about the drugs and their inclusion in these products, please see the previous recall.
Product details:
- MINCE BELLE (Dietary Supplement)
- 30 capsules
- UPC Number 7503013203305
- EVERLAX (Dietary Supplement)
- 30 capsules
- UPC Number 7503013203046
- EVER SLIM (Dietary Supplement)
- 30 capsules
- UPC Number 7503013203053
- EVER SLIM Shake Mix (Dietary Supplement)
- Strawberry
- 17.6 ounce
- UPC Number 7503013203084
- EVER SLIM Shake Mix (Dietary Supplement)
- Chocolate
- 17.6 ounce
- UPC Number 7503013203077
- ACAI-MAN MANGOSTEEN Herbal Drink (Dietary Supplement)
- 16.6 ounce
- UPC Number 7503013203015
- PERFECT MEN (Dietary Supplement)
- 10 capsules
- UPC Number 7503013203190
The company says that, “Although there is no evidence suggesting that other lot numbers contain these substances, today Healthy People Co. announced an expanded recall of the company’s dietary supplements sold under the brand names described herein, to include all lot numbers sold on or before October 25, 2011.”
If you have purchased any of these products with any lot numbers on or before October 25, 2011, return to the store at 13105 Ramona Blvd., Ste F, in Irwindale, California 91706 for a full refund or replacement. For questions or instructions about the return process, you can call 1-626-939-4132 from 9:00 am to 5:00 pm PST from Monday through Friday.
If you have taken any of these products and experienced adverse effects, contact the FDA’s MedWatch Adverse Event Reporting Program.
